skip to Main Content

Experience by Indication

SOLID

Anaplastic Astrocytoma
Breast Cancer
Renal Cell Carcinoma
Basal Cell Carcinoma
Melanoma
Gastrointestinal Stromal Tumor
Ovarian Cancer
Prostate Cancer
Colorectal Cancer
Small Cell Lung Cancer
Hormone-Refractory Prostate Cancer
Non-Small Cell Lung Cancer
Gastric Cancer
Head & Neck
Glioblastoma
Bladder Cancer
Cervical Carcinoma
Fallopian Tube Cancer
Phase I Solid Tumors
Liver Cancer
Pancreatic Cancer
Pediatric Solid Tumors
Peritoneal Cancer
Rare Cancer Types
Urothelial Cancer

HEMATOLOGIC

Chronic Lymphocytic Leukemia
Chronic Myelogenous Leukemia
Chronic Myelomonocytic Leukemia
Non Hodgkin’s Lymphoma
 – Indolent B-Cell Lymphomas
– Follicular lymphoma (FL)
– Diffuse Large B-Cell lymphoma
– Small lymphocytic lymphoma (SLL)
– Marginal zone lymphoma
– Lymphoplasmacytic lymphoma
Acute Myeloid Leukaemia
Primary Central Nervous System Lymphoma (PCNSL)
Multiple Myeloma
Myelodysplastic syndromes (MDS)
Phase I Various Hematological Malignancies
Peripheral T-cell Lymphoma
Cutaneous T-cell Lymphoma

Experience by Drug Modalities

Cytotoxics
Antiangiogenic small molecules
Antigen Presenting Cell (APC)
Anti-metabolite
Antibody Drug Conjugates (ADC)
Biomarker
Chemotherapy
Gene therapies
Glutaminase inhibitors

Hormones
Hedgehog pathway inhibitors
Immunotherapeutic product obtained from leukapheresis
Monoclocal antibodies (mAb)
Oncologic vaccine
Oligonucleotide
Opioid
Peptides

Photosensitizing agent
Radiopharmaceuticals
Radioactive imaging agent
Recombinant DNA
(single-strand DNA)
Retroviral replicating vector
Small molecules
(Stem) cell therapies
Vaccines

Back To Top
×Close search
Search